• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

过氧化物酶体增殖物激活受体及其对心血管系统的影响。

PPARs and their effects on the cardiovascular system.

机构信息

Center for Cardiovascular Diseases, College of Pharmacy and Health Sciences, Texas Southern University, Houston, Texas 77004, USA.

出版信息

Clin Exp Hypertens. 2011;33(5):287-93. doi: 10.3109/10641963.2010.531845. Epub 2011 Jul 1.

DOI:10.3109/10641963.2010.531845
PMID:21721973
Abstract

Peroxisome proliferator-activated receptors (PPARs) are ligand-activated transcription factors belonging to the nuclear receptor superfamily that undergo transactivation or transrepression by distinct mechanisms leading to induction or repression of expression of target genes. The PPAR family consists of three isoforms, α, γ, and ß/δ, which share similar structural organization, possess distinct functions, and vary in their ligand affinity, expression, and activity in different metabolic pathways in different tissues. PPARs are involved in many functions especially those involved in the regulation of vascular tone, inflammation and energy homeostasis and therefore represent important targets for hypertension, obesity, obesity-induced inflammation, and metabolic syndrome in general. PPARs may influence the inflammatory response either by direct transcriptional downregulation of proinflammatory genes via mechanisms involving transrepression, or indirectly via their transcriptional effects on lipid metabolism. On account of their pleiotropic effects, they are now known to be active participants in many disease conditions and they represent potent targets for the development of therapy of a wide array of diseases.

摘要

过氧化物酶体增殖物激活受体 (PPARs) 是配体激活的转录因子,属于核受体超家族,通过不同的机制进行转录激活或转录抑制,从而诱导或抑制靶基因的表达。PPAR 家族由三个亚型,α、γ 和 ß/δ 组成,它们具有相似的结构组织,具有不同的功能,在不同组织的不同代谢途径中对配体的亲和力、表达和活性也不同。PPARs 参与许多功能,特别是涉及血管张力、炎症和能量平衡的调节,因此是高血压、肥胖、肥胖引起的炎症和代谢综合征等一般疾病的重要靶点。PPARs 可以通过涉及转录抑制的机制,直接转录下调促炎基因,或者通过对脂质代谢的转录效应间接影响炎症反应。由于其多效性作用,它们现在被认为是许多疾病状态的积极参与者,并且是开发广泛疾病治疗方法的有效靶点。

相似文献

1
PPARs and their effects on the cardiovascular system.过氧化物酶体增殖物激活受体及其对心血管系统的影响。
Clin Exp Hypertens. 2011;33(5):287-93. doi: 10.3109/10641963.2010.531845. Epub 2011 Jul 1.
2
PPAR and Pain.过氧化物酶体增殖物激活受体与疼痛
Int Rev Neurobiol. 2009;85:165-77. doi: 10.1016/S0074-7742(09)85013-7.
3
[Anti-inflammatory action of PPARs].[过氧化物酶体增殖物激活受体的抗炎作用]
Nihon Rinsho. 2005 Apr;63(4):609-15.
4
Drug Insight: mechanisms of action and therapeutic applications for agonists of peroxisome proliferator-activated receptors.药物洞察:过氧化物酶体增殖物激活受体激动剂的作用机制及治疗应用
Nat Clin Pract Endocrinol Metab. 2007 Feb;3(2):145-56. doi: 10.1038/ncpendmet0397.
5
Peroxisome proliferator-activated receptors and inflammation.过氧化物酶体增殖物激活受体与炎症
Pharmacol Ther. 2006 Jun;110(3):371-85. doi: 10.1016/j.pharmthera.2005.08.007. Epub 2005 Sep 15.
6
[Peroxisome proliferator-activated receptors (PPARs) in obesity and insulin resistance development].[过氧化物酶体增殖物激活受体(PPARs)在肥胖和胰岛素抵抗发展中的作用]
Rev Invest Clin. 2004 May-Jun;56(3):351-67.
7
Role of the PPAR family of nuclear receptors in the regulation of metabolic and cardiovascular homeostasis: new approaches to therapy.核受体PPAR家族在代谢和心血管稳态调节中的作用:新的治疗方法
Curr Opin Pharmacol. 2005 Apr;5(2):177-83. doi: 10.1016/j.coph.2004.11.004.
8
[Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].过氧化物酶体增殖物激活受体(PPARS)在脂质调节和炎症控制中的作用
J Soc Biol. 2002;196(1):47-52.
9
Peroxisome proliferator-activated receptors and inflammation: take it to heart.过氧化物酶体增殖物激活受体与炎症:牢记于心。
Acta Physiol (Oxf). 2007 Nov;191(3):171-88. doi: 10.1111/j.1748-1716.2007.01752.x.
10
PPARs: the vasculature, inflammation and hypertension.过氧化物酶体增殖物激活受体:血管系统、炎症与高血压
Curr Opin Nephrol Hypertens. 2009 Mar;18(2):128-33. doi: 10.1097/MNH.0b013e328325803b.

引用本文的文献

1
Potential involvement of peroxisome proliferator-activated receptors in the inhibition of mammary lipid synthesis during diet-induced milk fat depression.过氧化物酶体增殖物激活受体在饮食诱导的乳脂肪降低过程中对乳腺脂质合成的抑制作用中的潜在参与。
J Dairy Sci. 2025 Feb;108(2):2036-2044. doi: 10.3168/jds.2024-25575. Epub 2024 Nov 8.
2
The expanding roles of Nr6a1 in development and evolution.Nr6a1在发育和进化中的作用不断扩展。
Front Cell Dev Biol. 2024 Feb 19;12:1357968. doi: 10.3389/fcell.2024.1357968. eCollection 2024.
3
FKBP5 activates mitophagy by ablating PPAR-γ to shape a benign remyelination environment.
FKBP5 通过消除 PPAR-γ 来激活细胞自噬,从而塑造良性的髓鞘修复环境。
Cell Death Dis. 2023 Nov 11;14(11):736. doi: 10.1038/s41419-023-06260-7.
4
Peroxisome proliferator-activated receptors, farnesoid X receptor, and dual modulating drugs in hypertension.过氧化物酶体增殖物激活受体、法尼醇X受体与高血压中的双重调节药物
Front Physiol. 2023 Jun 23;14:1186477. doi: 10.3389/fphys.2023.1186477. eCollection 2023.
5
Recognition of fold- and function-specific sites in the ligand-binding domain of the thyroid hormone receptor-like family.识别甲状腺激素受体样家族配体结合域中的折叠和功能特定位点。
Front Endocrinol (Lausanne). 2022 Sep 29;13:981090. doi: 10.3389/fendo.2022.981090. eCollection 2022.
6
Potential therapeutic targets for age-related macular degeneration: The nuclear option.与年龄相关的黄斑变性的潜在治疗靶点:核选项。
Prog Retin Eye Res. 2023 May;94:101130. doi: 10.1016/j.preteyeres.2022.101130. Epub 2022 Oct 8.
7
Nuclear receptor Nr1d1 alleviates asthma by abating GATA3 gene expression and Th2 cell differentiation.核受体 Nr1d1 通过抑制 GATA3 基因表达和 Th2 细胞分化来缓解哮喘。
Cell Mol Life Sci. 2022 May 21;79(6):308. doi: 10.1007/s00018-022-04323-0.
8
Telmisartan Attenuates Kanamycin-Induced Ototoxicity in Rats.替米沙坦可减轻卡那霉素诱导的大鼠耳毒性。
Int J Mol Sci. 2021 Nov 24;22(23):12716. doi: 10.3390/ijms222312716.
9
and Pioglitazone Affect Systemic Inflammation and Oxidative Stress Induced by Inhaled Paraquat in Rats.吡格列酮对百草枯诱导大鼠系统炎症和氧化应激的影响。
Mediators Inflamm. 2021 May 4;2021:5575059. doi: 10.1155/2021/5575059. eCollection 2021.
10
Heart Failure in Type 2 Diabetes Mellitus.2 型糖尿病中的心力衰竭。
Circ Res. 2019 Jan 4;124(1):121-141. doi: 10.1161/CIRCRESAHA.118.311371.